BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24558109)

  • 1. Human cytomegalovirus-platelet interaction triggers toll-like receptor 2-dependent proinflammatory and proangiogenic responses.
    Assinger A; Kral JB; Yaiw KC; Schrottmaier WC; Kurzejamska E; Wang Y; Mohammad AA; Religa P; Rahbar A; Schabbauer G; Butler LM; Söderberg-Naucler C
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):801-9. PubMed ID: 24558109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein B100 danger-associated signal 1 (ApoBDS-1) triggers platelet activation and boosts platelet-leukocyte proinflammatory responses.
    Assinger A; Wang Y; Butler LM; Hansson GK; Yan ZQ; Söderberg-Nauclér C; Ketelhuth DF
    Thromb Haemost; 2014 Aug; 112(2):332-41. PubMed ID: 24816772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets.
    Bambace NM; Levis JE; Holmes CE
    Platelets; 2010; 21(2):85-93. PubMed ID: 20063989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation.
    Badrnya S; Schrottmaier WC; Kral JB; Yaiw KC; Volf I; Schabbauer G; Söderberg-Nauclér C; Assinger A
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):571-80. PubMed ID: 24371083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of platelet responses triggered by Toll-like receptor 2 and 4 ligands is another non-genomic role of nuclear factor-kappaB.
    Rivadeneyra L; Carestia A; Etulain J; Pozner RG; Fondevila C; Negrotto S; Schattner M
    Thromb Res; 2014 Feb; 133(2):235-43. PubMed ID: 24331207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2.
    Assinger A; Laky M; Schabbauer G; Hirschl AM; Buchberger E; Binder BR; Volf I
    J Thromb Haemost; 2011 Apr; 9(4):799-809. PubMed ID: 21251195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
    Gerdes N; Seijkens T; Lievens D; Kuijpers MJ; Winkels H; Projahn D; Hartwig H; Beckers L; Megens RT; Boon L; Noelle RJ; Soehnlein O; Heemskerk JW; Weber C; Lutgens E
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):482-90. PubMed ID: 26821950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase.
    Blair P; Rex S; Vitseva O; Beaulieu L; Tanriverdi K; Chakrabarti S; Hayashi C; Genco CA; Iafrati M; Freedman JE
    Circ Res; 2009 Feb; 104(3):346-54. PubMed ID: 19106411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD40 ligand stimulates CD40-dependent activation of the β2 integrin Mac-1 and protein kinase C zeda (PKCζ) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burst.
    Jin R; Yu S; Song Z; Zhu X; Wang C; Yan J; Wu F; Nanda A; Granger DN; Li G
    PLoS One; 2013; 8(6):e64631. PubMed ID: 23785403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism.
    Xiang B; Zhang G; Ren H; Sunkara M; Morris AJ; Gartner TK; Smyth SS; Li Z
    PLoS One; 2012; 7(12):e51037. PubMed ID: 23236426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton's Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell Interactions.
    Parra-Izquierdo I; Lakshmanan HHS; Melrose AR; Pang J; Zheng TJ; Jordan KR; Reitsma SE; McCarty OJT; Aslan JE
    Front Immunol; 2021; 12():729951. PubMed ID: 34527000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets directly enhance neutrophil transmigration in response to oxidised low-density lipoprotein.
    Badrnya S; Butler LM; Söderberg-Naucler C; Volf I; Assinger A
    Thromb Haemost; 2012 Oct; 108(4):719-29. PubMed ID: 22836389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
    Schrottmaier WC; Kral JB; Badrnya S; Assinger A
    Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia.
    Biswas S; Zimman A; Gao D; Byzova TV; Podrez EA
    Circ Res; 2017 Sep; 121(8):951-962. PubMed ID: 28775078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll like receptor 2/1 mediated platelet adhesion and activation on bacterial mimetic surfaces is dependent on src/Syk-signaling and purinergic receptor P2X1 and P2Y12 activation.
    Klarström Engström K; Brommesson C; Kälvegren H; Bengtsson T
    Biointerphases; 2014 Dec; 9(4):041003. PubMed ID: 25553878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor.
    Ward JR; Bingle L; Judge HM; Brown SB; Storey RF; Whyte MK; Dower SK; Buttle DJ; Sabroe I
    Thromb Haemost; 2005 Oct; 94(4):831-8. PubMed ID: 16270639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.
    Higashikuni Y; Tanaka K; Kato M; Nureki O; Hirata Y; Nagai R; Komuro I; Sata M
    J Am Heart Assoc; 2013 Nov; 2(6):e000267. PubMed ID: 24249711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets as Key Factors in Inflammation: Focus on CD40L/CD40.
    Cognasse F; Duchez AC; Audoux E; Ebermeyer T; Arthaud CA; Prier A; Eyraud MA; Mismetti P; Garraud O; Bertoletti L; Hamzeh-Cognasse H
    Front Immunol; 2022; 13():825892. PubMed ID: 35185916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil CD40 enhances platelet-mediated inflammation.
    Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
    Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.